Biogen, Ionis spinal muscular atrophy therapy meets study goal By: MarketWatch August 01, 2016 at 10:11 AM EDT Companies said nusinersen demonstrated statistically significant improvement in certain motor functions. Read More >> Related Stocks: Biogen Idec Ionis Pharmaceuticals